What does complex atypical hyperplasia mean?
In general, complex atypical hyperplasia refers to endometrial complex atypical hyperplasia. This condition indicates that the patient has a borderline lesion characterized by abnormal thickening of the endometrium. The specific analysis is as follows:
Endometrial complex atypical hyperplasia is a type of precancerous, borderline lesion associated with endometrial overgrowth and thickening. It results from cellular changes in the endometrial cells and is classified as a precancerous condition. If not treated promptly, it may progress to endometrial cancer. Therefore, comprehensive evaluation is necessary to determine the exact condition, and appropriate treatment should be selected based on diagnostic results to prevent further progression and irreversible consequences.
For younger patients who wish to preserve fertility, treatment under medical guidance may include medications such as progesterone soft capsules or estradiol valerate tablets. These drugs help transform the endometrial tissue. After three consecutive treatment cycles, the disease progression should be reassessed. For patients who are postmenopausal and do not desire future pregnancies, total hysterectomy (removal of the uterus) may be recommended under medical advice to prevent malignant transformation.
If any symptoms occur, patients should seek timely medical attention at a hospital to avoid delays in diagnosis and treatment.